PDB ID: 5VOF
Hetero Atom Contents
The number of atoms exceeds 100,000. So, it can not be displayed here.
Select unit:
Select hetatm:
Select chain: Sequence
Data format:
Color scheme of protein:
| Code | Name | Style | Show | Link | |
|---|---|---|---|---|---|
| CA | Calcium ion | PoSSuM | |||
| MG | Magnesium ion | PoSSuM | |||
| NA | Sodium ion | PoSSuM | |||
| RIV | 5-chloro-N-({(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide | PoSSuM |
| Code | Name | Show |
|---|---|---|
| CFL | 4-amino-1-(2-deoxy-2-fluoro-5-O-phosphono-beta-D-arabinofuranosyl)pyrimidin-2(1h)-one | |
| UFT | 2'-deoxy-2'-fluorouridine 5'-(dihydrogen phosphate) |
| Code | Name | Emphasize |
|---|
| Code | Name | Show |
|---|
Download interaction data: 5VOF
Structure summary
| Code : | 5VOF PDBj RCSB PDB PDBe | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Header : | HYDROLASE/HYDROLASE INHIBITOR/RNA | ||||||||||||||||||||||||||||||||||||
| Title : | DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban | ||||||||||||||||||||||||||||||||||||
| Release Data : | 2018-06-13 | ||||||||||||||||||||||||||||||||||||
| Compound : |
|
||||||||||||||||||||||||||||||||||||
| Source : |
|
||||||||||||||||||||||||||||||||||||
| Authors : | Krishnaswamy, S., Kumar, S. | ||||||||||||||||||||||||||||||||||||
| Keywords : | Serine Protease, Blood Coagulation, Aptamer, Inhibitor, HYDROLASE-HYDROLASE INHIBITOR-RNA complex | ||||||||||||||||||||||||||||||||||||
| Exp. method : | X-RAY DIFFRACTION ( 2.25 Å ) | ||||||||||||||||||||||||||||||||||||
| Citation : |
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.
Gunaratne, R.,Kumar, S.,Frederiksen, J.W.
et al.
PubMed: 29863725 |
||||||||||||||||||||||||||||||||||||
Reaction
| Chain : | L | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| UniProt : | P00742 (FA10_HUMAN) | ||||||||
|
|||||||||


